<DOC>
	<DOCNO>NCT02009644</DOCNO>
	<brief_summary>The purpose clinical trial ass evaluate safety efficacy Treovance Stent-Graft Navitel Delivery System subject Abdominal Aortic Aneurysms ( AAA ) .</brief_summary>
	<brief_title>Clinical Study Treovance Stent-Graft Patients With Abdominal Aortic Aneurysms</brief_title>
	<detailed_description>This phase II , multi-center , non-blinded , non-randomized study treatment Treovance Stent-Graft subject abdominal aortic aneurysm . The study include 150 subject treat Treovance Stent-Graft maximum 30 investigational site . There prospective control group . Subjects diagnose infrarenal abdominal aortic aneurysm enrol trial treat Treovance Stent-Graft Navitel Delivery System . Pre-procedure baseline data gather , well post-procedure assessment prior hospital discharge 30 day , 6 month , 12 month post-implantation . In addition , annual follow-up visit 5 year conduct . The primary goal study gather safety effectiveness data Treovance device . A maximum 150 endovascular subject require fulfill U.S . Phase II requirement . The data study submit FDA use support approval U.S . There two primary objective , efficacy safety Treovance Stent-Graft subject infrarenal aortic aneurysm : - Primary Efficacy evaluate successful aneurysm treatment 12 month post-implant - Primary Safety assess composite major adverse event ( MAE ) rate 30-days Secondary objective involve assessment major device-related event major morbidity .</detailed_description>
	<mesh_term>Aneurysm</mesh_term>
	<mesh_term>Aortic Aneurysm</mesh_term>
	<mesh_term>Aortic Aneurysm , Abdominal</mesh_term>
	<criteria>Subject must diagnose infrarenal abdominal aortic aneurysm ( AAA ) , without iliac artery involvement Subject must infrarenal AAA &gt; 4.5 cm diameter male , &gt; 4.0 cm diameter female , increase diameter 0.5 cm last 6 month Subject dissection abdominal aorta , rupture aneurysm , symptomatic aneurysm ( determined treat physician ) Subject prior AAA repair ( endovascular surgical ) Subject participate another research study , receive investigational study drug within 30 day plan procedure , receive investigational device within one year plan procedure</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>August 2015</verification_date>
	<keyword>Abdominal Aortic Aneurysm</keyword>
	<keyword>AAA</keyword>
	<keyword>Aneurysm</keyword>
</DOC>